Teflaro is a Intravenous Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Ceftaroline Fosamil.
Product ID | 0456-0400_0125d943-1b18-45f9-971f-4ee704ec54b7 |
NDC | 0456-0400 |
Product Type | Human Prescription Drug |
Proprietary Name | Teflaro |
Generic Name | Ceftaroline Fosamil |
Dosage Form | Powder, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2010-10-29 |
Marketing Category | NDA / NDA |
Application Number | NDA200327 |
Labeler Name | Allergan, Inc. |
Substance Name | CEFTAROLINE FOSAMIL |
Active Ingredient Strength | 400 mg/20mL |
Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2010-10-29 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA200327 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-10-29 |
Marketing Category | NDA |
Application Number | NDA200327 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-10-29 |
Ingredient | Strength |
---|---|
CEFTAROLINE FOSAMIL | 400 mg/20mL |
SPL SET ID: | 3ecde48b-75a2-4beb-9999-369f3f61bb8a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0456-0400 | Teflaro | ceftaroline fosamil |
0456-0600 | Teflaro | ceftaroline fosamil |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TEFLARO 85073011 3949340 Live/Registered |
ALLERGAN SALES, LLC 2010-06-28 |
TEFLARO 85018295 3935814 Live/Registered |
ALLERGAN SALES, LLC 2010-04-20 |